InsightsDecisions, Risk & Governance

A founder’s face can help sell the company’s products.

By Uttam Dinodia2 min readView this post on LinkedIn

Buying the company does not automatically buy everything behind that influence.

On 7 May 2026, the Delhi High Court granted interim protection to boAt co-founder and Shark Tank India judge Aman Gupta against unauthorized exploitation of his identity.

His complaint described fake endorsements, unauthorized merchandise and AI impersonation. The court restrained specified defendants from misusing his name, image, voice and other attributes.

It did not decide what rights boAt holds under its arrangements with Gupta.

For investors and boards, that distinction opens a larger question: how much of the business depends on the person?

Martha Stewart’s company shows why checking the paperwork is only half the work.

Before her 2004 conviction, Martha Stewart Living Omnimedia already held an exclusive, worldwide, perpetual, royalty-free license to use her name and likeness for its products and services, subject to contractual conditions.

Then Stewart was convicted on 5 March 2004. The company later reported that its flagship television program’s availability fell from about 90% to 50% of US television households, attributing the decline to the trial’s outcome.

The license secured permission to use her identity. It could not secure the market’s response.

That is the distinction to carry into due diligence: rights to use a founder’s identity and dependence on the founder’s reputation are separate questions.

Before valuing a founder-led brand, ask:

• Rights: What can the company use, and what changes if the founder leaves or control changes?

• Dependence: Which sales, partnerships, and customer relationships rely on the founder’s involvement or reputation?

• Resilience: What evidence shows that customers will follow the product and team without the founder?

Use those answers to test the valuation under different scenarios.

A founder can create a premium. The work is establishing how much of it can endure beyond them.

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.